Ludovica Borsoi

Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies

Rosanna Tarricone, Fabio Michele Amatucci, Patrizio Armeni et al. · Health Policy · 2021 · 43 citations · Full text

Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry

Carla Rognoni, Diego Cuccurullo, Ludovica Borsoi et al. · Scientific Reports · 2020 · 39 citations · Full text

Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia

Michela Meregaglia, Ludovica Borsoi, John Cairns et al. · The European Journal of Health Economics · 2017 · 21 citations · Full text

Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service

Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro et al. · Clinical Therapeutics · 2020 · 21 citations

Medicine, Cancer Management, Net Monetary Benefit +5

Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service

Patrizio Armeni, Ludovica Borsoi, Giulia Fornaro et al. · Clinical Therapeutics · 2020 · 13 citations

Medicine, Cancer Management, Gynecology +8